It is a prescription medication, widely stocked at pharmacies, and prescribable today by any qualified provider
As research in this field continues to evolve, ongoing and future CVOTs will likely expand our knowledge of the cardiovascular benefits of GLP-1 receptor agonists, ultimately improving the care and outcomes of individuals with T2D and CVD
Beyond glycemic endpoints, GLP-1s are being evaluated for cardiometabolic and neuroprotective roles, expanding their use across specialties (Nauck & Meier, 2020
Our board-certified dermatologists are here to help with compassionate, expert care
The future of this class of drugs looks promising, with investigations underway into combinations with SGLT2 inhibitors, as well as oral and inhalable formulations (Neumiller et al., 2020)
Glutathione-mimetic D609 alleviates memory deficits and reduces amyloid-beta deposition in an AbetaPP/PS1 transgenic mouse model